160 related articles for article (PubMed ID: 36978237)
1. Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple-Negative Breast Cancer Treatment.
Torres Quintas S; Canha-Borges A; Oliveira MJ; Sarmento B; Castro F
Small; 2023 Mar; ():e2300666. PubMed ID: 36978237
[TBL] [Abstract][Full Text] [Related]
2. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
Miller-Kleinhenz JM; Bozeman EN; Yang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
[TBL] [Abstract][Full Text] [Related]
3. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer.
Jain V; Kumar H; Anod HV; Chand P; Gupta NV; Dey S; Kesharwani SS
J Control Release; 2020 Oct; 326():628-647. PubMed ID: 32653502
[TBL] [Abstract][Full Text] [Related]
4. Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.
Luo C; Wang P; He S; Zhu J; Shi Y; Wang J
Front Oncol; 2022; 12():919072. PubMed ID: 35795050
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy.
Yang R; Li Y; Wang H; Qin T; Yin X; Ma X
Mol Biomed; 2022 Mar; 3(1):8. PubMed ID: 35243562
[TBL] [Abstract][Full Text] [Related]
6. The application of exosomes in the treatment of triple-negative breast cancer.
Weaver JW; Zhang J; Rojas J; Musich PR; Yao Z; Jiang Y
Front Mol Biosci; 2022; 9():1022725. PubMed ID: 36438660
[TBL] [Abstract][Full Text] [Related]
7. Advances in Therapeutic Approaches for Triple-Negative Breast Cancer.
Mahtani R; Kittaneh M; Kalinsky K; Mamounas E; Badve S; Vogel C; Lower E; Schwartzberg L; Pegram M;
Clin Breast Cancer; 2021 Oct; 21(5):383-390. PubMed ID: 33781662
[TBL] [Abstract][Full Text] [Related]
8. Triple-negative breast cancer: advancements in characterization and treatment approach.
Hurvitz S; Mead M
Curr Opin Obstet Gynecol; 2016 Feb; 28(1):59-69. PubMed ID: 26694831
[TBL] [Abstract][Full Text] [Related]
9. A Review on Nanocarrier Mediated Treatment and Management of Triple Negative Breast Cancer: A Saudi Arabian Scenario.
Nahvi I; Belkahla S; Biswas S; Chakraborty S
Front Oncol; 2022; 12():953865. PubMed ID: 35941873
[TBL] [Abstract][Full Text] [Related]
10. Research advances and new challenges in overcoming triple-negative breast cancer.
Zong Y; Pegram M
Cancer Drug Resist; 2021; 4(3):517-542. PubMed ID: 34888495
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer.
Chadar R; Afsana ; Kesharwani P
Int J Pharm; 2021 Aug; 605():120835. PubMed ID: 34197908
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC).
Kanugo A; Gautam RK; Kamal MA
Curr Pharm Biotechnol; 2022; 23(13):1581-1595. PubMed ID: 34967294
[TBL] [Abstract][Full Text] [Related]
13. Narrowing the focus: Therapeutic cell surface targets for refractory triple-negative breast cancer.
Tafreshi NK; Morse DL; Lee MC
World J Clin Oncol; 2020 Apr; 11(4):169-179. PubMed ID: 32355639
[TBL] [Abstract][Full Text] [Related]
14. An overview of triple-negative breast cancer.
Kumar P; Aggarwal R
Arch Gynecol Obstet; 2016 Feb; 293(2):247-69. PubMed ID: 26341644
[TBL] [Abstract][Full Text] [Related]
15. Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies.
Khosravi-Shahi P; Cabezón-Gutiérrez L; Custodio-Cabello S
Asia Pac J Clin Oncol; 2018 Feb; 14(1):32-39. PubMed ID: 28815913
[TBL] [Abstract][Full Text] [Related]
16. Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous disease.
Mehlich D; Marusiak AA
Cancer Lett; 2022 Oct; 547():215775. PubMed ID: 35667515
[TBL] [Abstract][Full Text] [Related]
17. Triple negative breast cancer: looking for the missing link between biology and treatments.
Palma G; Frasci G; Chirico A; Esposito E; Siani C; Saturnino C; Arra C; Ciliberto G; Giordano A; D'Aiuto M
Oncotarget; 2015 Sep; 6(29):26560-74. PubMed ID: 26387133
[TBL] [Abstract][Full Text] [Related]
18. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
Qattan A
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
[TBL] [Abstract][Full Text] [Related]
19. Applications of Extracellular Vesicles in Triple-Negative Breast Cancer.
St-Denis-Bissonnette F; Khoury R; Mediratta K; El-Sahli S; Wang L; Lavoie JR
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053616
[TBL] [Abstract][Full Text] [Related]
20. Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC).
Chaudhuri A; Kumar DN; Dehari D; Singh S; Kumar P; Bolla PK; Kumar D; Agrawal AK
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
